Moderna Inc.
SubsidiaryDetails
- UID
- org-modernainc
Notes
Founded: 2010 Role: Co-Founder & Chairman IPO: December 2018 (NASDAQ: MRNA) Description: mRNA therapeutics and vaccine company Market Cap: $40B+ (as of 2024) Notable: Developed one of first COVID-19 vaccines
Relationship Strength
Loading relationships...